Presentation is loading. Please wait.

Presentation is loading. Please wait.

C-MYC overexpression or growth in serum-containing media induces EMT in HBEC3p53,KRAS. c-MYC overexpression or growth in serum-containing media induces.

Published bySissel Martha Arnesen Modified over 5 years ago

Similar presentations

Presentation on theme: "C-MYC overexpression or growth in serum-containing media induces EMT in HBEC3p53,KRAS. c-MYC overexpression or growth in serum-containing media induces."— Presentation transcript:

1 c-MYC overexpression or growth in serum-containing media induces EMT in HBEC3p53,KRAS.
c-MYC overexpression or growth in serum-containing media induces EMT in HBEC3p53,KRAS. A, phase contrast photomicrographs showing the morphologic effect observed in HBEC3p53,KRAS (left) following overexpression of c-MYC (middle) or switching from defined serum-free media to serum-containing media (right; ×20 magnification). B, immunoblot for EMT markers in oncogenically manipulated HBEC3 and HBEC17 grown in either KSFM (serum-free) or serum-containing (R10) media. The presence (+) or absence (−) of serum is shown. C, EMT-related genes altered 4-fold or greater in pairwise analysis of HBEC3p53,KRAS and HBEC3p53,KRAS,cMYC comparing cells grown in serum or defined medium (KSFM). Values log2 transformed. *, P < 0.05; **, P < 0.01 (t test). Full-length blots are presented in Supplementary Fig. S8. Mitsuo Sato et al. Mol Cancer Res 2013;11: ©2013 by American Association for Cancer Research

Download ppt "C-MYC overexpression or growth in serum-containing media induces EMT in HBEC3p53,KRAS. c-MYC overexpression or growth in serum-containing media induces."

Similar presentations

A B C D Supplementary Figure 1 CMV p300

A B C D Supplementary Figure 1 CMV p300
HER2 mutations V777L, D769H, V842I, G309A induce gain-of-function over HER2 WT in MCF10A mammary epithelial cells. HER2 mutations V777L, D769H, V842I,

HER2 mutations V777L, D769H, V842I, G309A induce gain-of-function over HER2 WT in MCF10A mammary epithelial cells. HER2 mutations V777L, D769H, V842I,
miR-133a positively regulated p53/p21 pathway.

miR-133a positively regulated p53/p21 pathway.
Pirh2 promotes p73 ubiquitination in vivo.

Pirh2 promotes p73 ubiquitination in vivo.
Characterization and capture of CK− cells after induction of EMT

Characterization and capture of CK− cells after induction of EMT
Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.

Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.
miR-335 targeted RANKL and reduced osteoclast induction in SBC-5.

miR-335 targeted RANKL and reduced osteoclast induction in SBC-5.
Volume 17, Issue 1, Pages (January 2005)

Volume 17, Issue 1, Pages (January 2005)
p38 MAPK activation is required for phosphorylation of Akt at Ser473.

p38 MAPK activation is required for phosphorylation of Akt at Ser473.
Susan J. Clark, Peter L. Molloy  Cancer Cell 

Susan J. Clark, Peter L. Molloy  Cancer Cell 
Thermomorphogenesis in seedling organs is autonomous or interdependent

Thermomorphogenesis in seedling organs is autonomous or interdependent
Fig. 1. Ovarian cancer spheroids can bud from a monolayer

Fig. 1. Ovarian cancer spheroids can bud from a monolayer
Fig. 2. Ex vivo inducible knockout of PDCD2 in ESCs results in loss of S phase entry and increased p53.(A) Growth curve of inducible knockout and WT ESCs.

Fig. 2. Ex vivo inducible knockout of PDCD2 in ESCs results in loss of S phase entry and increased p53.(A) Growth curve of inducible knockout and WT ESCs.
Fig. 1 TET2 is a coactivator of ERα.

Fig. 1 TET2 is a coactivator of ERα.
USP2a regulates MYC expression through the MDM2–p53 axis.

USP2a regulates MYC expression through the MDM2–p53 axis.
IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.

IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.
The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.

The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.
Enrichment of 3-aa motifs upon addition of Ery.

Enrichment of 3-aa motifs upon addition of Ery.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.

A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
GA blocks HIF activity and reduces HIF target expression.

GA blocks HIF activity and reduces HIF target expression.

Similar presentations

Ads by Google